aTYR PHARMA INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
aTYR PHARMA INC (ATYR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$3.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-07
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$266.00K, a 105.53% decline year-over-year.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$3.47M.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$536.00K, a 164.97% decline year-over-year.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $18.00K, a 99.20% decline year-over-year.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$33.00K.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.34M, a 141.05% decline from fiscal 2023.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $3.26M, a 51.61% decline from fiscal 2022.
- aTYR PHARMA INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $6.74M, a 14242.55% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$3.73M 10-Q · filed 2026-08-07 | -$4.27M derived: sum of 3 quarters · filed 2026-08-07 | -$4.25M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$3.47M 10-Q · filed 2026-05-15 | -$4.00M derived: sum of 2 quarters · filed 2026-05-15 | -$3.98M derived: sum of 3 quarters · filed 2026-05-15 | $822.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$518.00K derived: sum of 2 quarters · filed 2026-03-05 | $4.29M derived: sum of 3 quarters · filed 2026-08-07 | -$33.00K 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.83M derived: sum of 2 quarters · filed 2026-08-07 | $503.00K 10-Q · filed 2025-11-06 | $1.33M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $485.00K 10-Q · filed 2026-08-07 | $1.31M derived: sum of 3 quarters · filed 2026-08-07 | $3.55M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$4.32M 10-Q · filed 2026-05-15 | -$3.50M derived: sum of 2 quarters · filed 2026-05-15 | -$1.25M derived: sum of 3 quarters · filed 2026-05-15 | -$5.43M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.07M derived: sum of 2 quarters · filed 2026-03-05 | -$1.11M derived: sum of 3 quarters · filed 2026-03-05 | -$1.34M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.94M derived: sum of 2 quarters · filed 2025-11-06 | -$2.16M 10-Q · filed 2025-11-06 | $1.22M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | -$4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.41M 10-Q · filed 2025-08-07 | -$1.02M derived: sum of 3 quarters · filed 2026-03-05 | -$126.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | -$228.00K 10-Q · filed 2025-05-07 | $3.16M derived: sum of 2 quarters · filed 2026-03-05 | $4.05M derived: sum of 3 quarters · filed 2026-03-05 | $4.09M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.28M derived: sum of 2 quarters · filed 2026-03-05 | $4.32M derived: sum of 3 quarters · filed 2026-03-05 | $3.26M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $893.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $931.00K derived: sum of 2 quarters · filed 2024-11-07 | -$126.00K 10-Q · filed 2024-11-07 | $1.74M derived: sum of 4 quarters · filed 2025-03-13 | ||||
| 2023-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.02M 10-Q · filed 2024-08-13 | $844.00K derived: sum of 3 quarters · filed 2025-03-13 | $2.61M derived: sum of 4 quarters · filed 2025-03-13 | ||||
| 2023-03-31 | -$1.06M 10-Q · filed 2024-05-02 | $806.00K derived: sum of 2 quarters · filed 2025-03-13 | $2.58M derived: sum of 3 quarters · filed 2025-03-13 | $5.47M derived: sum of 4 quarters · filed 2025-03-13 | ||||
| 2022-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $3.63M derived: sum of 2 quarters · filed 2025-03-13 | $6.53M derived: sum of 3 quarters · filed 2025-03-13 | $6.74M 10-K · filed 2025-03-13 | ||||
| 2022-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.66M derived: sum of 2 quarters · filed 2023-11-09 | $4.88M 10-Q · filed 2023-11-09 | $5.06M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | $2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.11M 10-Q · filed 2023-08-09 | $3.29M derived: sum of 3 quarters · filed 2024-03-14 | $1.78M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $216.00K 10-Q · filed 2023-05-09 | $396.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.12M derived: sum of 3 quarters · filed 2024-03-14 | $1.78M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$1.33M derived: sum of 2 quarters · filed 2024-03-14 | $1.57M derived: sum of 3 quarters · filed 2024-03-14 | $47.00K 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.39M derived: sum of 2 quarters · filed 2022-11-14 | -$133.00K 10-Q · filed 2022-11-14 | $768.00K derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.38M 10-Q · filed 2022-08-15 | $2.28M derived: sum of 3 quarters · filed 2023-03-14 | $2.55M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-03-31 | -$1.52M 10-Q · filed 2022-05-10 | -$620.00K derived: sum of 2 quarters · filed 2023-03-14 | -$347.00K derived: sum of 3 quarters · filed 2023-03-14 | $820.00K derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2020-12-31 | $901.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.17M derived: sum of 2 quarters · filed 2023-03-14 | $2.34M derived: sum of 3 quarters · filed 2023-03-14 | $1.76M 10-K · filed 2023-03-14 | ||||
| 2020-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.44M derived: sum of 2 quarters · filed 2021-11-12 | $862.00K 10-Q · filed 2021-11-12 | $1.18M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $589.00K 10-Q · filed 2021-08-11 | $186.00K 10-Q · filed 2020-08-13 | $910.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.57M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-03-31 | -$578.00K 10-Q · filed 2021-05-14 | -$257.00K derived: sum of 2 quarters · filed 2022-03-15 | $400.00K derived: sum of 3 quarters · filed 2022-03-15 | $569.00K derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2019-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $978.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.15M derived: sum of 3 quarters · filed 2022-03-15 | $162.00K 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | $657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $826.00K derived: sum of 2 quarters · filed 2020-11-13 | -$159.00K 10-Q · filed 2020-11-13 | -$78.00K derived: sum of 4 quarters · filed 2021-03-24 | ||||
| 2019-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$816.00K 10-Q · filed 2020-08-13 | -$735.00K derived: sum of 3 quarters · filed 2021-03-24 | -$1.09M derived: sum of 4 quarters · filed 2021-03-24 | ||||
| 2019-03-31 | -$985.00K 10-Q · filed 2020-05-12 | -$904.00K derived: sum of 2 quarters · filed 2021-03-24 | -$1.26M derived: sum of 3 quarters · filed 2021-03-24 | -$2.04M derived: sum of 4 quarters · filed 2021-03-24 | ||||
| 2018-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$278.00K derived: sum of 2 quarters · filed 2021-03-24 | -$1.06M derived: sum of 3 quarters · filed 2021-03-24 | -$2.06M 10-K · filed 2021-03-24 | ||||
| 2018-09-30 | -$359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.14M derived: sum of 2 quarters · filed 2019-11-14 | -$2.14M 10-Q · filed 2019-11-14 | -$4.30M derived: sum of 4 quarters · filed 2020-03-26 | ||||
| 2018-06-30 | -$781.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$1.78M 10-Q · filed 2019-08-14 | -$3.94M derived: sum of 3 quarters · filed 2020-03-26 | -$3.25M derived: sum of 4 quarters · filed 2020-03-26 | ||||
| 2018-03-31 | -$999.00K 10-Q · filed 2019-05-14 | -$3.16M derived: sum of 2 quarters · filed 2020-03-26 | -$2.47M derived: sum of 3 quarters · filed 2020-03-26 | -$1.10M derived: sum of 4 quarters · filed 2020-03-26 | ||||
| 2017-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$1.47M derived: sum of 2 quarters · filed 2020-03-26 | -$97.00K derived: sum of 3 quarters · filed 2020-03-26 | -$2.89M 10-K · filed 2020-03-26 | -$2.49M 10-K · filed 2018-03-20 | |||
| 2017-09-30 | $691.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $2.07M derived: sum of 2 quarters · filed 2018-11-14 | -$725.00K 10-Q · filed 2018-11-14 | -$444.00K 10-Q · filed 2017-11-14 | -$1.77M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2017-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.42M 10-Q · filed 2018-08-14 | -$1.25M 10-Q · filed 2017-08-14 | -$2.46M derived: sum of 3 quarters · filed 2019-03-26 | -$3.50M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2017-03-31 | -$2.79M 10-Q · filed 2018-05-15 | -$2.74M 10-Q · filed 2017-05-11 | -$3.84M derived: sum of 2 quarters · filed 2019-03-26 | -$4.87M derived: sum of 3 quarters · filed 2019-03-26 | -$4.71M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2016-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$2.08M derived: sum of 2 quarters · filed 2019-03-26 | -$1.92M derived: sum of 3 quarters · filed 2019-03-26 | -$932.00K 10-K · filed 2019-03-26 | ||||
| 2016-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$871.00K derived: sum of 2 quarters · filed 2017-11-14 | $112.00K 10-Q · filed 2017-11-14 | $3.34M derived: sum of 4 quarters · filed 2018-03-20 | ||||
| 2016-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.15M 10-Q · filed 2017-08-14 | $4.37M derived: sum of 3 quarters · filed 2018-03-20 | $4.37M derived: sum of 4 quarters · filed 2018-03-20 | ||||
| 2016-03-31 | $983.00K 10-Q · filed 2017-05-11 | $4.21M derived: sum of 2 quarters · filed 2018-03-20 | $4.21M derived: sum of 3 quarters · filed 2018-03-20 | $4.16M derived: sum of 4 quarters · filed 2018-03-20 | ||||
| 2015-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $3.23M derived: sum of 2 quarters · filed 2018-03-20 | $3.18M derived: sum of 3 quarters · filed 2018-03-20 | $3.94M 10-K · filed 2018-03-20 | ||||
| 2015-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$47.00K derived: sum of 2 quarters · filed 2016-11-14 | $718.00K 10-Q · filed 2016-11-14 | $610.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $717.00K 10-Q · filed 2016-08-10 | $609.00K derived: sum of 3 quarters · filed 2017-03-16 | $863.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $765.00K 10-Q · filed 2016-05-11 | $657.00K derived: sum of 2 quarters · filed 2017-03-16 | $911.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.29M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $146.00K derived: sum of 2 quarters · filed 2017-03-16 | $525.00K derived: sum of 3 quarters · filed 2017-03-16 | -$207.00K 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $633.00K derived: sum of 2 quarters · filed 2015-11-10 | -$99.00K 10-Q · filed 2015-11-10 | |||||
| 2014-06-30 | $379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$353.00K 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$732.00K 10-Q · filed 2015-06-18 | |||||||
| 2013-12-31 | $1.53M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |